Literature DB >> 11291552

Malignant fibrous histiocytoma: an institutional review.

J F Gibbs1, P P Huang, R J Lee, B McGrath, J Brooks, B McKinley, D Driscoll, W G Kraybill.   

Abstract

BACKGROUND: A thorough understanding of malignant fibrous histiocytoma (MFH), the most common subtype of soft tissue sarcoma, will lead to improved histologic-specific protocols.
METHODS: 126 patients with histologically confirmed MFH were analyzed. The median follow-up was 42 months (range 1-233 months).
RESULTS: Overall survival was 58% at 5 years and 38% at 10 years. Grade significantly influenced prognosis, with 10-year survival of 90%, 60%, and 20% for low, intermediate, and high grade tumors, respectively (p = 0.0007). Distant metastases at initial presentation (p = 0.0002) and size of the primary tumor (p = 0.0007) influenced outcome. Neither anatomic site nor depth of the primary tumor were significant prognostic factors. Positive microscopic margins were associated with a decreased disease-free survival (p = 0.006).
CONCLUSIONS: Tumor grade, size, and distant metastases at initial presentation remain the most important prognostic factors for MFH. Resection with negative microscopic margins decreased the incidence of local recurrence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291552     DOI: 10.1081/cnv-100000071

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  24 in total

Review 1.  Malignant fibrous histiocytoma: past, present, and future.

Authors:  A E Rosenberg
Journal:  Skeletal Radiol       Date:  2003-09-27       Impact factor: 2.199

2.  Orthopaedic case of the month: A 30-year-old woman with a painful forearm mass.

Authors:  J Hochfelder; L D Rybak; R Garcia; J C Wittig
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

3.  Spontaneous expectoration of lung tumour mass.

Authors:  Krishna B Sharma
Journal:  CMAJ       Date:  2005-04-26       Impact factor: 8.262

4.  Primary malignant fibrous histiocytoma of the chest wall misdiagnosed as traumatic hemothorax.

Authors:  Ki-Eun Hwang; June-Seong Hwang; Kyung-Min Kim; Jae-Wan Jung; Su-Jin Oh; Eun-Kyoung Kim; Dae-Woon Ryu; Keum-Ha Choi; Eun-Taik Jeong; Hak-Ryul Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-06-28

5.  The first ever reported case of malignant fibrous histiocytoma of the scalp.

Authors:  Francesco Marongiu; Andrea Giurdanella; Francesca Fiorentini; Corrado Rubino
Journal:  Int Wound J       Date:  2018-08-30       Impact factor: 3.315

6.  Clinical report on transarterial neoadjuvant chemotherapy of malignant fibrous histiocytoma in soft tissue.

Authors:  Jun Guo; Qiu Cui; Cheng Liu; Jiahong Sui; Ning Jiang; Ju Zhou; Dingfeng Li; Yanjun Zeng
Journal:  Clin Transl Oncol       Date:  2012-09-14       Impact factor: 3.405

7.  Peritoneal dissemination from malignant fibrous histiocytoma of the buttock: unusual metastases from a rare tumor.

Authors:  Jung-Wan Yoo; Dae Ho Lee; Ho June Song; Jin-Hee Ahn; Sang-We Kim; Cheolwon Suh; Jung Shin Lee
Journal:  Gut Liver       Date:  2008-12-31       Impact factor: 4.519

Review 8.  Radiation-induced malignant fibrous histiocytoma of the maxilla.

Authors:  Takafumi Satomi; Masato Watanabe; Tadayoshi Kaneko; Jun Matsubayashi; Toshitaka Nagao; Hiroshige Chiba
Journal:  Odontology       Date:  2011-04-13       Impact factor: 2.634

9.  Undifferentiated pleomorphic sarcoma: indolent, tail-like recurrence of a high-grade tumor.

Authors:  Justin S Alpert; Patrick Boland; Meera Hameed; David M Panicek
Journal:  Skeletal Radiol       Date:  2017-09-20       Impact factor: 2.199

10.  Malignant fibrous histiocytoma of chest wall.

Authors:  Jin-Kyung An; Ki Keun Oh
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.